West Fraser Timber Co. Ltd. (“West Fraser” or the “Company”) (TSX and NYSE: WFG) announced today that it will indefinitely curtail its oriented strand board (OSB) mill in High Level, Alberta in the spring of 2026 following an orderly wind-down and consumption of the mill's existing log supply. Today's decision is the result of a […]

Ann Arbor, MI – AgelessRx, a leading longevity and telehealth platform dedicated to helping individuals extend their healthspan, announced the release of a new educational resource titled “A Guide to GLP-1s.” The guide provides a clear, accessible overview of GLP-1 therapies, including how they work, who may benefit most, and how they fit into long-term

Pittsburgh, PA – Fragasso Financial Advisors (“Fragasso”) today announced the release of a new educational blog titled “Understanding the New Enhanced Senior Tax Deduction: What Retirees Need to Know.” The web article and video summary provides retirees and those nearing retirement with a practical explanation of the upcoming deduction changes taking effect in 2025, along

The board of directors of WEC Energy Group (NYSE: WEC) today announced that it is planning to raise the quarterly dividend on the company's common stock to 95.25 cents per share in the first quarter of 2026. This would represent an increase of 6.0 cents per share, or 6.7 percent. The directors expect to declare

(TSX:PRN),(NASDAQ:PROF), TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, is pleased to announce that Pejman Ghanouni, MD, PhD, Associate Professor in the Department of Radiology, Division of Body

(NASDAQ:CRVO), Phase 2b trial showed significant improvements on primary and key secondary outcomes measures, most prominently in patients without AD co-pathology Significant reduction in key neurodegeneration biomarker correlated with treatment response, suggesting neflamapimod may act on underlying disease CervoMed preparing to initiate Phase 3 registrational trial in patients with DLB in the second half of

(TSX:K),(NYSE:KGC), (All dollar amounts are expressed in U.S. dollars, unless otherwise noted.) TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) — Kinross Gold Corporation (TSX: K; NYSE: KGC) (“Kinross”) announced today that Moody's Investors Service (“Moody's”) has upgraded the senior unsecured rating of Kinross to Baa2 from Baa3. The outlook has been changed to stable from positive.

(TSE:6963.T), Santa Clara, CA and Kyoto, Japan, Dec. 04, 2025 (GLOBE NEWSWIRE) — ROHM Semiconductor today announced they have begun mass production of the SCT40xxDLL series of SiC MOSFETs in TOLL (TO-Leadless) packages. Compared to conventional packages (TO-263-7L) with equivalent voltage ratings and on-resistance, these new packages offer approximately 39% improved thermal performance. This enables

(NASDAQ:AVAH), ATLANTA, Dec. 04, 2025 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the BofA Securities Home Care Conference virtually on December 9, 2025. Management will present at 12:30pm EST and will also host 1×1 investor meetings that same day. Interested investors and other parties

Washington D.C., Dec. 04, 2025 (GLOBE NEWSWIRE) — Grunt Style Foundation formally submitted testimony this week to the Senate Veterans Affairs Committee (SVAC) during its hearing on Medication Management and Polypharmacy in the 119th Congress. The testimony, delivered by Derek Blume, Veteran Fellow for Grunt Style Foundation, voiced strong support for the Written Informed Consent